Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
Pfizer Inc. ( NYSE:PFE ) just released its first-quarter report and things are looking bullish. It was overall a...
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.